ClearPoint Neuro outlines 5 IRRAflow milestones for 2027 as it prepares for potential AMT-130 approval timeline

ClearPoint Neuro Q3 2026 earnings: revenue rose 36%, burn improved, and AMT-130 FDA catalyst nears.

CryptoAlerta — análise de criptomoedas e mercado em tempo real